MedTrace Logo

Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2

NCT04868097 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2021-04-30

No results posted yet for this study

Summary

A pre- operative evaluation for the presence of intermediate risk factors prior to surgery may allow for better patient counselling, modify the course of surgery or select patients to undergo primary chemo- radiation.

The purpose of this study is to validate that the presence of histological risk factors in a pre-operative large loop biopsy highly correlates with post-operative histological evaluation and the subsequent indication for post-operative chemo-radiation

Conditions

  • Cancer of the Cervix
  • Conization of the Cervix
  • Radiation Therapy

Interventions

PROCEDURE

cervix biopsy

large loop electrosurgical cervix biopsy

Sponsors & Collaborators

  • Barzilai Medical Center

    collaborator OTHER

  • Hillel Yaffe Medical Center

    collaborator OTHER_GOV

  • Kaplan Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04868097 on ClinicalTrials.gov